Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Tyra Biosciences, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +3 vs. Q1 2022
- Shares held
- 35.7M
- −387.7K (−1.1%) vs. Q1 2022
- Total value
- $255.6M
- −$131.0M (−33.9%) vs. Q1 2022
- New holders
- 6
- 18 more added
- Sold out
- 3
- 16 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TYRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 168 | $2.22B |
| Q1 2026 | 164 | $2.54B |
| Q4 2025 | 133 | $1.49B |
| Q3 2025 | 116 | $779.4M |
| Q2 2025 | 121 | $541.7M |
| Q1 2025 | 117 | $499.5M |
| Q4 2024 | 113 | $675.8M |
| Q3 2024 | 95 | $1.11B |
| Q2 2024 | 79 | $754.4M |
| Q1 2024 | 77 | $775.8M |
| Q4 2023 | 62 | $501.2M |
| Q3 2023 | 59 | $502.1M |
| Q2 2023 | 59 | $616.7M |
| Q1 2023 | 51 | $623.6M |
| Q4 2022 | 46 | $267.8M |
| Q3 2022 | 49 | $319.8M |
| Q2 2022 | 48 | $255.6M |
| Q1 2022 | 46 | $386.6M |
| Q4 2021 | 45 | $503.6M |
| Q3 2021 | 26 | $456.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Tyra Biosciences, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 7,236,454 | $51.7M | 1.38% | 00.0% | Unchanged |
| Boxer Capital, LLC | 6,448,359 | $46.1M | 2.92% | 00.0% | Unchanged |
| Canaan Partners XI LLC | 4,409,991 | $31.5M | 11.23% | 00.0% | Unchanged |
| FMR LLC | 3,968,090 | $28.4M | 0.00% | −121,995−3.0% | Reduced |
| Nextech Invest AG | 2,518,582 | $18.0M | 6.07% | 00.0% | Unchanged |
| BVF Inc | 2,472,327 | $17.7M | 0.85% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 1,416,998 | $10.1M | 2.32% | +132,008+10.3% | Added |
| Frazier Life Sciences Management, L.P. | 1,375,065 | $9.83M | 0.93% | +47,400+3.6% | Added |
| TCG Crossover Management, LLC | 896,418 | $6.41M | 2.72% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 743,988 | $5.32M | 0.41% | −13,444−1.8% | Reduced |
| Janus Henderson Group PLC | 712,299 | $5.09M | 0.00% | −196,893−21.7% | Reduced |
| BlackRock Inc. | 630,855 | $4.51M | 0.00% | +47,619+8.2% | Added |
| Vanguard Group Inc | 591,109 | $4.23M | 0.00% | +75,472+14.6% | Added |
| Perceptive Advisors LLC | 494,403 | $3.54M | 0.11% | 00.0% | Unchanged |
| Woodline Partners LP | 289,172 | $2.07M | 0.03% | +23,011+8.6% | Added |
| Geode Capital Management, LLC | 225,411 | $1.61M | 0.00% | +14,862+7.1% | Added |
| JPMorgan Chase & Co | 224,492 | $1.60M | 0.00% | −3,990−1.7% | Reduced |
| State Street Corp | 214,025 | $1.53M | 0.00% | +10,345+5.1% | Added |
| Logos Global Management LP | 166,526 | $1.19M | 0.22% | −86,200−34.1% | Reduced |
| Sio Capital Management, LLC | 152,159 | $1.09M | 0.43% | +41,126+37.0% | Added |
| Northern Trust Corp | 103,134 | $738.0K | 0.00% | +3,030+3.0% | Added |
| Charles Schwab Investment Management Inc | 81,301 | $582.0K | 0.00% | +845+1.1% | Added |
| Citadel Advisors LLC | 74,845 | $535.0K | 0.00% | −3,464−4.4% | Reduced |
| D. E. Shaw & Co., Inc. | 56,054 | $401.0K | 0.00% | −27,384−32.8% | Reduced |
| Wellington Management Group LLP | 54,864 | $392.0K | 0.00% | −196,358−78.2% | Reduced |
| Bank of New York Mellon Corp | 31,911 | $228.0K | 0.00% | +1,291+4.2% | Added |
| LPL Financial LLC | 20,500 | $147.0K | 0.00% | +20,500 | New |
| Bank of America Corp | 19,719 | $141.0K | 0.00% | −44,407−69.2% | Reduced |
| Nuveen Asset Management, LLC | 18,756 | $134.0K | 0.00% | +356+1.9% | Added |
| Rhumbline Advisers | 17,285 | $124.0K | 0.00% | +5,559+47.4% | Added |
| Susquehanna International Group, LLP | 16,663 | $119.0K | 0.00% | +16,663 | New |
| Morgan Stanley | 13,436 | $96.0K | 0.00% | +11,865+755.3% | Added |
| Bailard, Inc. | 12,910 | $92.0K | 0.00% | +12,910 | New |
| New York State Common Retirement Fund | 10,488 | $75.0K | 0.00% | −29−0.3% | Reduced |
| American International Group, Inc. | 6,142 | $44.0K | 0.00% | +286+4.9% | Added |
| Deutsche Bank AG | 5,797 | $41.0K | 0.00% | −816−12.3% | Reduced |
| California State Teachers Retirement System | 5,612 | $40.0K | 0.00% | +548+10.8% | Added |
| Tower Research Capital LLC (TRC) | 2,937 | $21.0K | 0.00% | +1,694+136.3% | Added |
| Amalgamated Bank | 1,621 | $12.0K | 0.00% | −150−8.5% | Reduced |
| Legal & General Group Plc | 961 | $7.00K | 0.00% | −165−14.7% | Reduced |
| Citigroup Inc | 934 | $7.00K | 0.00% | +475+103.5% | Added |
| Ameritas Investment Partners, Inc. | 940 | $6.00K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 658 | $5.00K | 0.00% | −1,257−65.6% | Reduced |
| Wells Fargo & Company | 153 | $1.00K | 0.00% | −2,409−94.0% | Reduced |
| Royal Bank of Canada | 74 | $1.00K | 0.00% | −651−89.8% | Reduced |
| The PNC Financial Services Group, Inc. | 58 | $0 | 0.00% | +58 | New |
| Credit Suisse AG | 34 | $0 | 0.00% | +34 | New |
| Advisor Group Holdings, Inc. | 1 | $0 | 0.00% | +1 | New |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −29,300−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,740−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |